Twenty-nine ( @ % ) patients exhibited adverse reactions , @ % exhibited excitation , @ % suffered from insomnia , @ % had headaches , @ % had erythra , @ % suffered from abdominal pain , and @ % exhibited an increased glutamic-pyruvate transaminase level .